PolyPeptide Group / Key word (s): Expansion Doubling of production capacity at the manufacturing site in Malmö 08.01.2025 / 07:00 CET/CEST ...

New in vivo preclinical data announced today, demonstrate that icovamenib, in combination with semaglutide showed additional 11.5% body weight ...

Peptide Therapeutics MarketThe global peptide therapeutics market is on a strong growth trajectory, with sales projected to ...

Peptide Synthesis IndustryThe global peptide synthesis market is poised for significant growth, with its valuation projected to increase from USD 520.0 million in 2023 to an impressive USD 1.1 billion ...

In a significant step towards advancing scientific research, InfinityChem has unveiled its latest research and manufacturing facility in Scottsdale, Arizona. The new facility is primed to produce ...

( MENAFN - GlobeNewsWire - Nasdaq) Germany's peptide therapeutics market is set to grow at a 3.3% CAGR from 2024 to 2034, driven by strong healthcare systems, favorable policies, and the rise of ...

Peptides are amino acid polymers. They are generally much smaller than proteins and don’t have sufficient activity on their own – they generally represent a small portion of a full protein ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

In addition to acquiring Nimble's drug candidates, AbbVie will gain access to the company's advanced peptide synthesis, screening, and optimization platform. Nimble's roots trace back to 1999 ...

Additionally, AbbVie will acquire Nimble’s peptide synthesis, screening, and optimization platform, which uses proprietary ...

It also encompasses Nimble’s advanced peptide synthesis, screening and optimisation platform, which leverages proprietary technology to expedite the discovery and refinement of peptide candidates for ...